8,695,653 Shares of Common Stock La Jolla Pharmaceutical Company Common Stock Underwriting AgreementLa Jolla Pharmaceutical Co • February 20th, 2004 • Biological products, (no disgnostic substances) • California
La Jolla Pharmaceutical Company, a Delaware corporation (the “Company”), proposes to issue and sell to you as the Underwriter (the “Underwriter”) an aggregate of 8,695,653 shares of Common Stock, $0.01 par value per share (the "Common Stock”), of the Company (the “Firm Shares”). In addition, solely for the purpose of covering over-allotments, the Company proposes to grant to the Underwriter the option to purchase from the Company up to an additional 1,304,347 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares (to the extent the aforementioned option is exercised) are herein collectively referred to as the “Offered Securities.”
